adverse drug response
41Bisphenol A — Bisphenol A IUPAC name …
42Zolpidem — Systematic (IUPAC) name N,N dimethyl 2 (6 methyl 2 p t …
43Pharmacogenetics — The terms pharmacogenomics and pharmacogenetics tend to be used interchangeably, and a precise, consensus definition of either remains elusive. Pharmacogenetics is generally regarded as the study or clinical testing of genetic variation that… …
44Reliability of Wikipedia — Vandalism of a Wikipedia article. The section on the left is the normal, undamaged version; and on the right is the edited, damaged version. The reliabili …
45Cinoxacin — Systematic (IUPAC) name 1 Ethyl 1,4 Dihydro 4 oxo [1,3] Dioxolo [4,5 g] Cinnoline 3 Carboxylic Acid Clinical data AHFS/Drugs.com …
46therapeutics — /ther euh pyooh tiks/, n. (used with a sing. v.) the branch of medicine concerned with the remedial treatment of disease. [1665 75; see THERAPEUTIC, ICS] * * * Treatment and care to combat disease or alleviate pain or injury. Its tools include… …
47Vaccine injury — Classification and external resources ICD 10 T88.1, Y58 Y59 …
48COX-2 inhibitor — COX 2 selective inhibitor is a form of non steroidal anti inflammatory drug (NSAID) that directly targets COX 2, an enzyme responsible for inflammation and pain. Targeting selectivity for COX 2 reduces the risk of peptic ulceration, and is the… …
49Zopiclone — Systematic (IUPAC) name (RS) 6 (5 chloropyridin 2 yl) 7 oxo 6,7 dihydro 5H pyrrolo[3,4 b]pyrazin 5 yl 4 methylpiperazine 1 carboxylate Clinical data Trade n …
50Public Health Genomics — is the utilization of genomics information to benefit public health. This is visualized as more effective personalised preventive care and disease treatments with better specificity, targeted to the genetic makeup of each patient. (Bellagio Group …
